New study has discovered why some prostate cancers are more aggressive, spread to different parts of the body, and ultimately cause death. This discovery could transform patient treatment, says a new study.

The new study shows how the number of 'aggressive' cells in a tumor sample defines how quickly the disease will progress and spread.
The findings also reveal three new subtypes of prostate cancer that could be used to stratify patients for different treatments.
Lead researcher Prof Colin Cooper, from UEA's Norwich Medical School, said: "Prostate cancer is the most common cancer in men in the UK. It usually develops slowly, and the majority of cancers will not require treatment in a man's lifetime. However, doctors struggle to predict which tumors will become aggressive, making it hard to decide on treatment for many men.
"This means that many thousands of men are treated unnecessarily, increasing the risk of damaging side effects, including impotence from surgery."
The team developed a test to distinguish aggressive prostate cancers from less threatening forms of the disease, by applying some complex maths known as Latent Process Decomposition.
Advertisement
In the latest study, published today, the team studied gene expression levels in 1,785 tumor samples. They found that the amount of DESNT subtype cells in a sample is linked with the likelihood of disease progression - the more DESNT cells, the quicker the patient is likely to progress.
Advertisement
"We also identified three more molecular subtypes of prostate cancer that could help doctors decide on different treatment options for patients. "This research highlights the importance of using more complex approaches for the analysis of genomic data," he added.
Source-Eurekalert